drugset / Trial / NCT00247117
Metformin in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to examine the effect of metformin on biochemical and histological findings in NAFLD patients with insulin resistance syndrome.
Timeline
- Start
- 2004-01
- Primary completion
- —
- Completion
- 2005-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 850 mg | — |